Advent Life Sciences LLP 13D/13G Filings for Aura Biosciences, Inc. (AURA)

Advent Life Sciences LLP 13D and 13G filings for Aura Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-02-17
8:48 pm
Purchase		2026-02-1313GAURA BIOSCIENCES INC
AURA		Advent Life Sciences LLP2,071,857
3.335%		48,000increase
(+2.37%)		Filing
2022-02-11
5:59 pm
Purchase		2021-12-3113GAURA BIOSCIENCES INC
AURA		Advent Life Sciences LLP2,023,857
6.900%		2,023,857increase
(New Position)		Filing